Observational study of the Clinical Practice in patients with Borderline resectable or resectable or advanced pancreatic adenocarcinoma.
Study Type
OBSERVATIONAL
Enrollment
200
clinical practice-treatments
Time frame: 2 years
progression Free Survival
Time frame: 2 years
Overall Survival
Time frame: 2 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.